Triodos Investment Management BV Has $47.52 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Triodos Investment Management BV lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 91,037 shares of the medical equipment provider’s stock after selling 12,700 shares during the period. Intuitive Surgical makes up 3.8% of Triodos Investment Management BV’s holdings, making the stock its 4th largest position. Triodos Investment Management BV’s holdings in Intuitive Surgical were worth $47,518,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of ISRG. Bennett Selby Investments LP boosted its position in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock worth $234,000 after acquiring an additional 17 shares during the period. Onefund LLC grew its holdings in Intuitive Surgical by 1.9% during the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider’s stock valued at $494,000 after purchasing an additional 18 shares during the last quarter. LVW Advisors LLC boosted its holdings in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after acquiring an additional 19 shares during the period. Wesbanco Bank Inc. increased its position in Intuitive Surgical by 1.6% in the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock worth $635,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.7% during the 4th quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider’s stock valued at $275,000 after purchasing an additional 19 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. UBS Group increased their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Evercore ISI raised their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Finally, Bernstein Bank upped their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Trading Down 0.2 %

NASDAQ ISRG opened at $507.90 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The business’s 50-day moving average price is $558.29 and its two-hundred day moving average price is $532.25. The firm has a market capitalization of $180.90 billion, a PE ratio of 79.24, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This trade represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.